What does the PANSS mean?
- PMID: 15982856
- DOI: 10.1016/j.schres.2005.04.008
What does the PANSS mean?
Abstract
Objective: Despite the frequent use of the Positive and Negative Syndrome Scale (PANSS) for rating the symptoms of schizophrenia, the clinical meaning of its total score and of the cut-offs that are used to define treatment response (e.g. at least 20% or 50% reduction of the baseline score) are as yet unclear. We therefore compared the PANSS with simultaneous ratings of Clinical Global Impressions (CGI).
Method: PANSS and CGI ratings at baseline (n = 4091), and after one, two, four and six weeks of treatment taken from a pooled database of seven pivotal, multi-center antipsychotic drug trials on olanzapine or amisulpride in patients with exacerbations of schizophrenia were compared using equipercentile linking.
Results: Being considered "mildly ill" according to the CGI approximately corresponded to a PANSS total score of 58, "moderately ill" to a PANSS of 75, "markedly ill" to a PANSS of 95 and severely ill to a PANSS of 116. To be "minimally improved" according to the CGI score was associated with a mean percentage PANSS reduction of 19%, 23%, 26% and 28% at weeks 1, 2, 4 and 6, respectively. The corresponding figures for a CGI rating "much improved" were 40%, 45%, 51% and 53%.
Conclusions: The results provide a better framework for understanding the clinical meaning of the PANSS total score in drug trials of schizophrenia patients with acute exacerbations. Such studies may ideally use at least a 50% reduction from baseline cut-off to define response rather than lower thresholds. In treatment resistant populations, however, even a small improvement can be important, so that a 25% cut-off might be appropriate.
Similar articles
-
Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia.Neuropsychopharmacology. 2019 Aug;44(9):1589-1596. doi: 10.1038/s41386-019-0363-2. Epub 2019 Mar 5. Neuropsychopharmacology. 2019. PMID: 30836381 Free PMC article.
-
Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI.Schizophr Res. 2008 Jan;98(1-3):318-22. doi: 10.1016/j.schres.2007.09.006. Epub 2007 Oct 18. Schizophr Res. 2008. PMID: 17949948
-
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study.J Clin Psychopharmacol. 2010 Dec;30(6):726-31. doi: 10.1097/jcp.0b013e3181faf39b. J Clin Psychopharmacol. 2010. PMID: 21105273
-
Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?J Clin Psychiatry. 1999;60 Suppl 5:23-9; discussion 30. J Clin Psychiatry. 1999. PMID: 10192404 Review.
-
A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia.CNS Drugs. 2016 Jan;30(1):27-39. doi: 10.1007/s40263-015-0308-1. CNS Drugs. 2016. PMID: 26801655 Review.
Cited by
-
Efficacy of Horticultural Therapy on Positive, Negative, and Affective Symptoms in Individuals with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Healthcare (Basel). 2024 Oct 22;12(21):2104. doi: 10.3390/healthcare12212104. Healthcare (Basel). 2024. PMID: 39517317 Free PMC article. Review.
-
Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials.Schizophrenia (Heidelb). 2024 Nov 2;10(1):102. doi: 10.1038/s41537-024-00525-6. Schizophrenia (Heidelb). 2024. PMID: 39488504 Free PMC article.
-
Family-based interventions versus standard care for people with schizophrenia.Cochrane Database Syst Rev. 2024 Oct 4;10(10):CD013541. doi: 10.1002/14651858.CD013541.pub2. Cochrane Database Syst Rev. 2024. PMID: 39364773 Review.
-
Unidentified CYP2D6 genotype does not affect pharmacological treatment for patients with first episode psychosis.J Psychopharmacol. 2024 Dec;38(12):1111-1121. doi: 10.1177/02698811241279022. Epub 2024 Sep 29. J Psychopharmacol. 2024. PMID: 39344086 Free PMC article.
-
Clinical effects of CYP2D6 phenoconversion in patients with psychosis.J Psychopharmacol. 2024 Dec;38(12):1095-1110. doi: 10.1177/02698811241278844. Epub 2024 Sep 23. J Psychopharmacol. 2024. PMID: 39310932 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical